The Journal of Parkinson's Disease (JPD) publishes original research in basic science, translational research and clinical medicine in Parkinson’s disease in cooperation with the Journal of Alzheimer's Disease. It features a first class Editorial Board and provides rigorous peer review and rapid online publication.
From 2022, the journal publishes eight issues per annual volume; prior to this it was four issues per year..
For subscription information, click here.
JPD's targeted audience is comprised of basic science researchers and clinicians in the areas of Parkinson’s disease and related disorders.
JPD has a Journal Impact Factor of 5.568, a 5-Year Impact Factor of 5.732, and a Journal Citation Indicator of 0.94 (2020 Journal Citation Reports, source: Clarivate, 2021).
Chemical Abstracts Service (CAS), Embase, Journal Citation Reports/Science Edition, MEDLINE, PsycINFO, PubsHub, Science Citation Index-Expanded (SciSearch®), Scopus
To receive news and JAD updates, sign up via this link: http://tiny.cc/JPDsignup
Find JPD on Facebook at: facebook.com/journalpd
Follow JPD on Twitter at: twitter.com/journal_pd
IOS Press publishes publishes around 90 journals and 70 books annually in a broad range of subject categories, primarily specializing in biomedical and life sciences (including neurosciences, medical informatics, cancer research, rehabilitation) and physical sciences (including computer sciences, artificial intelligence, engineering).
Headquartered in Amsterdam with satellite offices in the USA, Germany and China, IOS Press continues its rapid growth, embracing new technologies for the timely dissemination of information.
All journals are available in print and electronic format.